Ipsen : 2023 CSM – Formalities for making available preparatory documents to the Meeting
Ipsen : 2023 CSM – Formalities for making available preparatory documents to the Meeting
INFORMATION RELATING TO THE HOLDING OF THE
COMBINED SHAREHOLDERS’ MEETING OF 31 MAY 2023
Ipsen : 2023 CSM – Formalities for making available preparatory documents to the Meeting
- 10 May 2023 - 1 mins read
INFORMATION RELATING TO THE HOLDING OF THE
COMBINED SHAREHOLDERS’ MEETING OF 31 MAY 2023
Related Press Releases
17 April 2024
4 mins read
Ipsen publishes its 2023 Universal Registration Document
08 April 2024
1 mins read
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
02 April 2024
7 mins read
Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors
07 March 2024
1 mins read
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
15 February 2024
1 mins read
Ipsen S.A. publishes its 2023 Consolidated Financial Statements
13 February 2024
14 mins read
Ipsen’s Onivyde® regimen, a potential new standard-of-care first-line therapy in metastatic pancreatic adenocarcinoma, approved by FDA
08 February 2024
8 mins read
Building on solid FY 2023 results, Ipsen anticipates four launches in 2024
06 February 2024
1 mins read
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
22 January 2024
10 mins read
Latest Phase III trial data investigating Cabometyx® in combination with immunotherapy to be presented at ASCO GU 2024
08 January 2024
1 mins read